Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cytokines in stem cell transplantation

F M Stewart1

  • 1Hematology-Oncology Division, University of Massachusetts Medical Center, Worcester 01655, USA.

Annals of the New York Academy of Sciences
|December 29, 1995
PubMed
Summary

Cytokines in stem cell transplantation show limited efficacy, requiring studies to prove patient benefit and survival advantages. Future research should identify patient subsets who benefit or are harmed by cytokine therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Two locus models of selection and mutation within and among full-sib lines.

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2013
Same author

Floating treatment wetlands for domestic wastewater treatment.

Water science and technology : a journal of the International Association on Water Pollution Research·2011
Same author

Comparison of matched unrelated and matched related donor myeloablative hematopoietic cell transplantation for adults with acute myeloid leukemia in first remission.

Leukemia·2010
Same author

Murine marrow cellularity and the concept of stem cell competition: geographic and quantitative determinants in stem cell biology.

Leukemia·2004
Same author

Low molecular weight heparin for the treatment of venous thromboembolism in pregnancy: a case series.

BJOG : an international journal of obstetrics and gynaecology·2002
Same author

Granulocyte-macrophage colony-stimulating factor (GM-CSF) priming with successive concomitant low-dose Ara-C for elderly patients with secondary/refractory acute myeloid leukemia or advanced myelodysplastic syndrome.

Leukemia·2002

Area of Science:

  • Hematology
  • Immunology
  • Regenerative Medicine

Background:

  • Cytokine use in stem cell transplantation is experimental.
  • Consistent efficacy has not yet been established.
  • Current applications lack proven patient benefit or survival advantage.

Purpose of the Study:

  • To evaluate the efficacy and patient benefit of cytokines in stem cell transplantation.
  • To determine if cytokines offer a survival advantage.
  • To explore precise cytokine application through biologic parameter determination.

Main Methods:

  • Clinical studies evaluating patient outcomes with cytokine therapy.
  • Assessment of therapeutic outcomes and survival rates.
  • Analysis of biologic parameters like cytokine receptors.

Main Results:

  • Cytokine efficacy in stem cell transplantation is not consistently established.
  • Patient benefit, palliation, and survival advantages require further validation.
  • Potential for both beneficial and harmful effects in different patient subsets.

Conclusions:

  • Cytokine therapy in stem cell transplantation requires rigorous study to confirm efficacy and safety.
  • Cost-effectiveness should not be considered until therapeutic benefits are proven.
  • Identifying patient subsets that benefit from or are harmed by cytokines is a critical future challenge.

Related Experiment Videos